AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations and asked for additional FDA funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, funding for specialized pharmacy resident programs, direct reimbursement under the Medicare program, inpatient hospital payments, and Electronics Health Records Incentive program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
S. 3187, H.R. 5651, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars, drug safety, expansion of over the counter (OTC) medicines. Communications to Health Resources and Services Administration on 340B drug discount program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.